Corton Capital’s Foghorn Therapeutics FHTX Stock Holding History

Corton Capital’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,576	Closed	-$163K	–	254
2024 Q4	$163K	Sell	34,576 -18,530	-35%	-$135K	0.09%	291
2024 Q3	$494K	Buy	53,106 +28,899	+119%	+$209K	0.24%	54
2024 Q2	$139K	Buy	+24,207	New	+$144K	0.07%	430

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corton Capital's FHTX Position: Q1 2025 in Review

Corton Capital sold out of Foghorn Therapeutics (FHTX) in Q1 2025, closing a stake of 34,576 shares — an estimated $163K sold.

Corton Capital first reported a position in FHTX in Q2 2024 and held it in 3 quarters. The position peaked at $494K in Q3 2024. 90 funds tracked by Wall St. Rank hold FHTX as of Q1 2025.

Corton Capital reported no remaining Foghorn Therapeutics position as of Q1 2025 after selling out during the quarter.
Corton Capital sold 34,576 Foghorn Therapeutics shares in Q1 2025, an estimated $163K.
Corton Capital first reported a position in Foghorn Therapeutics in Q2 2024 and held it in 3 quarters.
Corton Capital's Foghorn Therapeutics position peaked at $494K in Q3 2024.
90 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.